Optimal dose of lisinopril for renoprotection in type 1 diabetic patients with diabetic nephropathy: a randomised crossover trial View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2009-01

AUTHORS

K. J. Schjoedt, A. S. Astrup, F. Persson, E. Frandsen, F. Boomsma, K. Rossing, L. Tarnow, P. Rossing, H.-H. Parving

ABSTRACT

AIMS/HYPOTHESIS: The purpose of this study was to evaluate the optimal renoprotective effect of ultrahigh doses of lisinopril, as reflected by short-term changes in urinary albumin excretion rate (UAER), in type 1 diabetic patients with diabetic nephropathy. METHODS: At the Steno Diabetes Center, 49 type 1 diabetic patients with diabetic nephropathy completed this double-masked randomised crossover trial consisting of an initial washout period followed by three treatment periods each lasting 2 months, where all patients received lisinopril 20, 40 and 60 mg once daily in randomised order in addition to slow-release furosemide. Allocation was concealed by sequentially numbered opaque sealed envelopes. UAER, 24 h ambulatory blood pressure (ABP) and estimated GFR were determined at baseline and after each treatment period. RESULTS: All 49 patients completed all three treatment periods. Baseline values were: UAER (geometric mean [95% CI]) 362 (240-545) mg/24 h, 24 h ABP (mean [SD]) 142 (14)/74 (8) mmHg and estimated GFR 75 (29) ml min(-1) 1.73 m(-2). Reductions in UAER from baseline were 63%, 71% and 70%, respectively, with the increasing doses of lisinopril (p < 0.001). Compared with lisinopril 20 mg there was a further reduction in UAER of 23% with lisinopril 40 mg and 19% with 60 mg, p < 0.05. ABP was reduced from baseline by 10/5, 13/7 and 12/7 mmHg (p < 0.001 vs baseline, p < 0.05 for diastolic ABP 20 vs 40 mg, otherwise NS between doses). The difference in UAER between 20 and 40 mg lisinopril was significant after adjustment for changes in ABP (p < 0.01). Two patients were excluded from the study because of an increase in plasma creatinine and one because of high BP; otherwise the study medication was well tolerated with few, mild, dose-independent adverse effects. CONCLUSIONS/INTERPRETATION: Lisinopril 40 mg once daily is generally safe and offers additional reductions in BP and UAER in comparison with the currently recommended dose of 20 mg. Lisinopril 60 mg offers no further beneficial effect. TRIAL REGISTRATION: ClinicalTrials.gov NCT00118976. More... »

PAGES

46-49

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s00125-008-1184-8

DOI

http://dx.doi.org/10.1007/s00125-008-1184-8

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1020403395

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/18974967


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Albuminuria", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antihypertensive Agents", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cross-Over Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Diabetes Mellitus, Type 1", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Diabetic Angiopathies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Diabetic Nephropathies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Dose-Response Relationship, Drug", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Double-Blind Method", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Glomerular Filtration Rate", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Lisinopril", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Protective Agents", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Steno Diabetes Center", 
          "id": "https://www.grid.ac/institutes/grid.419658.7", 
          "name": [
            "Steno Diabetes Center, Niels Steensens Vej 1, NLC, 2820, Gentofte, Denmark"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Schjoedt", 
        "givenName": "K. J.", 
        "id": "sg:person.0623062715.35", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0623062715.35"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Steno Diabetes Center", 
          "id": "https://www.grid.ac/institutes/grid.419658.7", 
          "name": [
            "Steno Diabetes Center, Niels Steensens Vej 1, NLC, 2820, Gentofte, Denmark"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Astrup", 
        "givenName": "A. S.", 
        "id": "sg:person.0722133724.52", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0722133724.52"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Steno Diabetes Center", 
          "id": "https://www.grid.ac/institutes/grid.419658.7", 
          "name": [
            "Steno Diabetes Center, Niels Steensens Vej 1, NLC, 2820, Gentofte, Denmark"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Persson", 
        "givenName": "F.", 
        "id": "sg:person.01331053122.29", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01331053122.29"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Rigshospitalet", 
          "id": "https://www.grid.ac/institutes/grid.475435.4", 
          "name": [
            "Glostrup University Hospital, Glostrup, Denmark"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Frandsen", 
        "givenName": "E.", 
        "id": "sg:person.0723670105.58", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0723670105.58"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Erasmus University Medical Center", 
          "id": "https://www.grid.ac/institutes/grid.5645.2", 
          "name": [
            "Erasmus MC, Rotterdam, the Netherlands"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Boomsma", 
        "givenName": "F.", 
        "id": "sg:person.01331665241.81", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01331665241.81"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Steno Diabetes Center", 
          "id": "https://www.grid.ac/institutes/grid.419658.7", 
          "name": [
            "Steno Diabetes Center, Niels Steensens Vej 1, NLC, 2820, Gentofte, Denmark"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Rossing", 
        "givenName": "K.", 
        "id": "sg:person.01024662571.90", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01024662571.90"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Steno Diabetes Center", 
          "id": "https://www.grid.ac/institutes/grid.419658.7", 
          "name": [
            "Steno Diabetes Center, Niels Steensens Vej 1, NLC, 2820, Gentofte, Denmark"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Tarnow", 
        "givenName": "L.", 
        "id": "sg:person.01227640403.97", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01227640403.97"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Steno Diabetes Center", 
          "id": "https://www.grid.ac/institutes/grid.419658.7", 
          "name": [
            "Steno Diabetes Center, Niels Steensens Vej 1, NLC, 2820, Gentofte, Denmark"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Rossing", 
        "givenName": "P.", 
        "id": "sg:person.01036424445.54", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01036424445.54"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Aarhus University", 
          "id": "https://www.grid.ac/institutes/grid.7048.b", 
          "name": [
            "Rigshospitalet, Department of Medical Endocrinology, University Hospital of Copenhagen, Copenhagen, Denmark", 
            "Faculty of Health Science, University of Aarhus, Aarhus, Denmark"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Parving", 
        "givenName": "H.-H.", 
        "id": "sg:person.01036362324.03", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01036362324.03"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1161/01.cir.0000047526.08376.80", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1009104800"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1046/j.1523-1755.2002.00536.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1011320789", 
          "https://doi.org/10.1046/j.1523-1755.2002.00536.x"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/hjh.0b013e328277596e", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1012963183"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/hjh.0b013e328277596e", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1012963183"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.ki.5001580", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1022214388", 
          "https://doi.org/10.1038/sj.ki.5001580"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa0801317", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1032359861"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1365-2125.1989.tb03521.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1037167641"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1365-2125.1988.tb03342.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1051218387"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1111/j.1523-1755.2005.00511.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1053471411", 
          "https://doi.org/10.1111/j.1523-1755.2005.00511.x"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1523-1755.2005.00511.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1053471411"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.7326/0003-4819-145-4-200608150-00004", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1073708888"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2009-01", 
    "datePublishedReg": "2009-01-01", 
    "description": "AIMS/HYPOTHESIS: The purpose of this study was to evaluate the optimal renoprotective effect of ultrahigh doses of lisinopril, as reflected by short-term changes in urinary albumin excretion rate (UAER), in type 1 diabetic patients with diabetic nephropathy.\nMETHODS: At the Steno Diabetes Center, 49 type 1 diabetic patients with diabetic nephropathy completed this double-masked randomised crossover trial consisting of an initial washout period followed by three treatment periods each lasting 2 months, where all patients received lisinopril 20, 40 and 60 mg once daily in randomised order in addition to slow-release furosemide. Allocation was concealed by sequentially numbered opaque sealed envelopes. UAER, 24 h ambulatory blood pressure (ABP) and estimated GFR were determined at baseline and after each treatment period.\nRESULTS: All 49 patients completed all three treatment periods. Baseline values were: UAER (geometric mean [95% CI]) 362 (240-545) mg/24 h, 24 h ABP (mean [SD]) 142 (14)/74 (8) mmHg and estimated GFR 75 (29) ml min(-1) 1.73 m(-2). Reductions in UAER from baseline were 63%, 71% and 70%, respectively, with the increasing doses of lisinopril (p < 0.001). Compared with lisinopril 20 mg there was a further reduction in UAER of 23% with lisinopril 40 mg and 19% with 60 mg, p < 0.05. ABP was reduced from baseline by 10/5, 13/7 and 12/7 mmHg (p < 0.001 vs baseline, p < 0.05 for diastolic ABP 20 vs 40 mg, otherwise NS between doses). The difference in UAER between 20 and 40 mg lisinopril was significant after adjustment for changes in ABP (p < 0.01). Two patients were excluded from the study because of an increase in plasma creatinine and one because of high BP; otherwise the study medication was well tolerated with few, mild, dose-independent adverse effects.\nCONCLUSIONS/INTERPRETATION: Lisinopril 40 mg once daily is generally safe and offers additional reductions in BP and UAER in comparison with the currently recommended dose of 20 mg. Lisinopril 60 mg offers no further beneficial effect.\nTRIAL REGISTRATION: ClinicalTrials.gov NCT00118976.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1007/s00125-008-1184-8", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1001482", 
        "issn": [
          "0012-186X", 
          "1432-0428"
        ], 
        "name": "Diabetologia", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "52"
      }
    ], 
    "name": "Optimal dose of lisinopril for renoprotection in type 1 diabetic patients with diabetic nephropathy: a randomised crossover trial", 
    "pagination": "46-49", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "61376ac0c86e5caab06a2056c75a2d7196d537f6c5a898f12ec786fa2eaa0735"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "18974967"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "0006777"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s00125-008-1184-8"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1020403395"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s00125-008-1184-8", 
      "https://app.dimensions.ai/details/publication/pub.1020403395"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-11T14:27", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000373_0000000373/records_13073_00000000.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://link.springer.com/10.1007%2Fs00125-008-1184-8"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s00125-008-1184-8'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s00125-008-1184-8'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s00125-008-1184-8'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s00125-008-1184-8'


 

This table displays all metadata directly associated to this object as RDF triples.

232 TRIPLES      21 PREDICATES      55 URIs      37 LITERALS      25 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s00125-008-1184-8 schema:about N05e6c64605284aa9b0a3296ec55755cb
2 N0a6f00026cac4276822cd39309b4f2ce
3 N2b745c9e1ceb47c7b417262e76229737
4 N60980b2da96b42beb1977529db3272b0
5 N696dc09751d3427ab25ecf25ec87ae3e
6 N6b5a7942aa6e4a74b010426d66ce144f
7 N7a9fffe979b74024ae7b517c9be84447
8 N853623fe29ec4be5845e39f5bd145a4c
9 Na45a1babb33f41fc85c45fe18754312d
10 Na6474e4a6b8945b39b8c80c8a5f0313b
11 Na970ea97d7d046ea8898288673c0d57a
12 Nc04fe386b0364810bff298ceb44ae694
13 Nd16ec320ba8245a3b54e955f38318a06
14 Ndb4c4c3ef4ef440e887353d57f08c130
15 Ndcad7916994b411c90841abd0ede9282
16 Ne6e8f3793ff0478c999eee954f030291
17 anzsrc-for:11
18 anzsrc-for:1103
19 schema:author Nabf4bc9c63544b169efca7a33318ce27
20 schema:citation sg:pub.10.1038/sj.ki.5001580
21 sg:pub.10.1046/j.1523-1755.2002.00536.x
22 sg:pub.10.1111/j.1523-1755.2005.00511.x
23 https://doi.org/10.1056/nejmoa0801317
24 https://doi.org/10.1097/hjh.0b013e328277596e
25 https://doi.org/10.1111/j.1365-2125.1988.tb03342.x
26 https://doi.org/10.1111/j.1365-2125.1989.tb03521.x
27 https://doi.org/10.1111/j.1523-1755.2005.00511.x
28 https://doi.org/10.1161/01.cir.0000047526.08376.80
29 https://doi.org/10.7326/0003-4819-145-4-200608150-00004
30 schema:datePublished 2009-01
31 schema:datePublishedReg 2009-01-01
32 schema:description AIMS/HYPOTHESIS: The purpose of this study was to evaluate the optimal renoprotective effect of ultrahigh doses of lisinopril, as reflected by short-term changes in urinary albumin excretion rate (UAER), in type 1 diabetic patients with diabetic nephropathy. METHODS: At the Steno Diabetes Center, 49 type 1 diabetic patients with diabetic nephropathy completed this double-masked randomised crossover trial consisting of an initial washout period followed by three treatment periods each lasting 2 months, where all patients received lisinopril 20, 40 and 60 mg once daily in randomised order in addition to slow-release furosemide. Allocation was concealed by sequentially numbered opaque sealed envelopes. UAER, 24 h ambulatory blood pressure (ABP) and estimated GFR were determined at baseline and after each treatment period. RESULTS: All 49 patients completed all three treatment periods. Baseline values were: UAER (geometric mean [95% CI]) 362 (240-545) mg/24 h, 24 h ABP (mean [SD]) 142 (14)/74 (8) mmHg and estimated GFR 75 (29) ml min(-1) 1.73 m(-2). Reductions in UAER from baseline were 63%, 71% and 70%, respectively, with the increasing doses of lisinopril (p < 0.001). Compared with lisinopril 20 mg there was a further reduction in UAER of 23% with lisinopril 40 mg and 19% with 60 mg, p < 0.05. ABP was reduced from baseline by 10/5, 13/7 and 12/7 mmHg (p < 0.001 vs baseline, p < 0.05 for diastolic ABP 20 vs 40 mg, otherwise NS between doses). The difference in UAER between 20 and 40 mg lisinopril was significant after adjustment for changes in ABP (p < 0.01). Two patients were excluded from the study because of an increase in plasma creatinine and one because of high BP; otherwise the study medication was well tolerated with few, mild, dose-independent adverse effects. CONCLUSIONS/INTERPRETATION: Lisinopril 40 mg once daily is generally safe and offers additional reductions in BP and UAER in comparison with the currently recommended dose of 20 mg. Lisinopril 60 mg offers no further beneficial effect. TRIAL REGISTRATION: ClinicalTrials.gov NCT00118976.
33 schema:genre research_article
34 schema:inLanguage en
35 schema:isAccessibleForFree true
36 schema:isPartOf N8ba344a87d574a28a443f40e86c5ea40
37 Ncfe9c82b319f4f1cb079abc6ae8deb88
38 sg:journal.1001482
39 schema:name Optimal dose of lisinopril for renoprotection in type 1 diabetic patients with diabetic nephropathy: a randomised crossover trial
40 schema:pagination 46-49
41 schema:productId N97094a8d69c6471eb6cc32c04f893b2c
42 N97137d09afca4d5b9adacd4e110b2b24
43 Nb31af23761244f6ca87e1e0a79b52099
44 Nf58fa2239f354a418f4a631cca02d836
45 Nfff75d16dd29436aa78fe4f13e3d4824
46 schema:sameAs https://app.dimensions.ai/details/publication/pub.1020403395
47 https://doi.org/10.1007/s00125-008-1184-8
48 schema:sdDatePublished 2019-04-11T14:27
49 schema:sdLicense https://scigraph.springernature.com/explorer/license/
50 schema:sdPublisher N9b5af44d66954d228ba31ba1c46ddc1d
51 schema:url https://link.springer.com/10.1007%2Fs00125-008-1184-8
52 sgo:license sg:explorer/license/
53 sgo:sdDataset articles
54 rdf:type schema:ScholarlyArticle
55 N05e6c64605284aa9b0a3296ec55755cb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
56 schema:name Protective Agents
57 rdf:type schema:DefinedTerm
58 N0a6f00026cac4276822cd39309b4f2ce schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
59 schema:name Female
60 rdf:type schema:DefinedTerm
61 N0bec72bc87a34778a42750eb5126dc40 rdf:first sg:person.01036362324.03
62 rdf:rest rdf:nil
63 N2b745c9e1ceb47c7b417262e76229737 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
64 schema:name Humans
65 rdf:type schema:DefinedTerm
66 N40adde256b574703aed1c27f6955cc8d rdf:first sg:person.01227640403.97
67 rdf:rest N4e7de8f9f51f4b12a5ea3277e8f28328
68 N44421da01ce84454b88e3b64c6373c6b rdf:first sg:person.01331053122.29
69 rdf:rest N77c89abe9fa441b0b5a7de3429ac4944
70 N4e7de8f9f51f4b12a5ea3277e8f28328 rdf:first sg:person.01036424445.54
71 rdf:rest N0bec72bc87a34778a42750eb5126dc40
72 N60980b2da96b42beb1977529db3272b0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
73 schema:name Glomerular Filtration Rate
74 rdf:type schema:DefinedTerm
75 N696dc09751d3427ab25ecf25ec87ae3e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
76 schema:name Antihypertensive Agents
77 rdf:type schema:DefinedTerm
78 N6b5a7942aa6e4a74b010426d66ce144f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
79 schema:name Lisinopril
80 rdf:type schema:DefinedTerm
81 N77c89abe9fa441b0b5a7de3429ac4944 rdf:first sg:person.0723670105.58
82 rdf:rest N9e42a200a3b844ee874abc5e95f50622
83 N7a9fffe979b74024ae7b517c9be84447 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
84 schema:name Middle Aged
85 rdf:type schema:DefinedTerm
86 N853623fe29ec4be5845e39f5bd145a4c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
87 schema:name Male
88 rdf:type schema:DefinedTerm
89 N8ba344a87d574a28a443f40e86c5ea40 schema:volumeNumber 52
90 rdf:type schema:PublicationVolume
91 N97094a8d69c6471eb6cc32c04f893b2c schema:name readcube_id
92 schema:value 61376ac0c86e5caab06a2056c75a2d7196d537f6c5a898f12ec786fa2eaa0735
93 rdf:type schema:PropertyValue
94 N97137d09afca4d5b9adacd4e110b2b24 schema:name nlm_unique_id
95 schema:value 0006777
96 rdf:type schema:PropertyValue
97 N9b5af44d66954d228ba31ba1c46ddc1d schema:name Springer Nature - SN SciGraph project
98 rdf:type schema:Organization
99 N9e42a200a3b844ee874abc5e95f50622 rdf:first sg:person.01331665241.81
100 rdf:rest Naf485b59f3474a9eb61a440dc1896010
101 Na45a1babb33f41fc85c45fe18754312d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
102 schema:name Double-Blind Method
103 rdf:type schema:DefinedTerm
104 Na6474e4a6b8945b39b8c80c8a5f0313b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
105 schema:name Albuminuria
106 rdf:type schema:DefinedTerm
107 Na970ea97d7d046ea8898288673c0d57a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
108 schema:name Diabetic Nephropathies
109 rdf:type schema:DefinedTerm
110 Nabf4bc9c63544b169efca7a33318ce27 rdf:first sg:person.0623062715.35
111 rdf:rest Nb912cd91d3094cf48c33a1553b646d61
112 Naf485b59f3474a9eb61a440dc1896010 rdf:first sg:person.01024662571.90
113 rdf:rest N40adde256b574703aed1c27f6955cc8d
114 Nb31af23761244f6ca87e1e0a79b52099 schema:name pubmed_id
115 schema:value 18974967
116 rdf:type schema:PropertyValue
117 Nb912cd91d3094cf48c33a1553b646d61 rdf:first sg:person.0722133724.52
118 rdf:rest N44421da01ce84454b88e3b64c6373c6b
119 Nc04fe386b0364810bff298ceb44ae694 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
120 schema:name Dose-Response Relationship, Drug
121 rdf:type schema:DefinedTerm
122 Ncfe9c82b319f4f1cb079abc6ae8deb88 schema:issueNumber 1
123 rdf:type schema:PublicationIssue
124 Nd16ec320ba8245a3b54e955f38318a06 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
125 schema:name Diabetic Angiopathies
126 rdf:type schema:DefinedTerm
127 Ndb4c4c3ef4ef440e887353d57f08c130 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
128 schema:name Diabetes Mellitus, Type 1
129 rdf:type schema:DefinedTerm
130 Ndcad7916994b411c90841abd0ede9282 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
131 schema:name Cross-Over Studies
132 rdf:type schema:DefinedTerm
133 Ne6e8f3793ff0478c999eee954f030291 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
134 schema:name Adult
135 rdf:type schema:DefinedTerm
136 Nf58fa2239f354a418f4a631cca02d836 schema:name dimensions_id
137 schema:value pub.1020403395
138 rdf:type schema:PropertyValue
139 Nfff75d16dd29436aa78fe4f13e3d4824 schema:name doi
140 schema:value 10.1007/s00125-008-1184-8
141 rdf:type schema:PropertyValue
142 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
143 schema:name Medical and Health Sciences
144 rdf:type schema:DefinedTerm
145 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
146 schema:name Clinical Sciences
147 rdf:type schema:DefinedTerm
148 sg:journal.1001482 schema:issn 0012-186X
149 1432-0428
150 schema:name Diabetologia
151 rdf:type schema:Periodical
152 sg:person.01024662571.90 schema:affiliation https://www.grid.ac/institutes/grid.419658.7
153 schema:familyName Rossing
154 schema:givenName K.
155 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01024662571.90
156 rdf:type schema:Person
157 sg:person.01036362324.03 schema:affiliation https://www.grid.ac/institutes/grid.7048.b
158 schema:familyName Parving
159 schema:givenName H.-H.
160 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01036362324.03
161 rdf:type schema:Person
162 sg:person.01036424445.54 schema:affiliation https://www.grid.ac/institutes/grid.419658.7
163 schema:familyName Rossing
164 schema:givenName P.
165 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01036424445.54
166 rdf:type schema:Person
167 sg:person.01227640403.97 schema:affiliation https://www.grid.ac/institutes/grid.419658.7
168 schema:familyName Tarnow
169 schema:givenName L.
170 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01227640403.97
171 rdf:type schema:Person
172 sg:person.01331053122.29 schema:affiliation https://www.grid.ac/institutes/grid.419658.7
173 schema:familyName Persson
174 schema:givenName F.
175 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01331053122.29
176 rdf:type schema:Person
177 sg:person.01331665241.81 schema:affiliation https://www.grid.ac/institutes/grid.5645.2
178 schema:familyName Boomsma
179 schema:givenName F.
180 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01331665241.81
181 rdf:type schema:Person
182 sg:person.0623062715.35 schema:affiliation https://www.grid.ac/institutes/grid.419658.7
183 schema:familyName Schjoedt
184 schema:givenName K. J.
185 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0623062715.35
186 rdf:type schema:Person
187 sg:person.0722133724.52 schema:affiliation https://www.grid.ac/institutes/grid.419658.7
188 schema:familyName Astrup
189 schema:givenName A. S.
190 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0722133724.52
191 rdf:type schema:Person
192 sg:person.0723670105.58 schema:affiliation https://www.grid.ac/institutes/grid.475435.4
193 schema:familyName Frandsen
194 schema:givenName E.
195 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0723670105.58
196 rdf:type schema:Person
197 sg:pub.10.1038/sj.ki.5001580 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022214388
198 https://doi.org/10.1038/sj.ki.5001580
199 rdf:type schema:CreativeWork
200 sg:pub.10.1046/j.1523-1755.2002.00536.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1011320789
201 https://doi.org/10.1046/j.1523-1755.2002.00536.x
202 rdf:type schema:CreativeWork
203 sg:pub.10.1111/j.1523-1755.2005.00511.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1053471411
204 https://doi.org/10.1111/j.1523-1755.2005.00511.x
205 rdf:type schema:CreativeWork
206 https://doi.org/10.1056/nejmoa0801317 schema:sameAs https://app.dimensions.ai/details/publication/pub.1032359861
207 rdf:type schema:CreativeWork
208 https://doi.org/10.1097/hjh.0b013e328277596e schema:sameAs https://app.dimensions.ai/details/publication/pub.1012963183
209 rdf:type schema:CreativeWork
210 https://doi.org/10.1111/j.1365-2125.1988.tb03342.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1051218387
211 rdf:type schema:CreativeWork
212 https://doi.org/10.1111/j.1365-2125.1989.tb03521.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1037167641
213 rdf:type schema:CreativeWork
214 https://doi.org/10.1111/j.1523-1755.2005.00511.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1053471411
215 rdf:type schema:CreativeWork
216 https://doi.org/10.1161/01.cir.0000047526.08376.80 schema:sameAs https://app.dimensions.ai/details/publication/pub.1009104800
217 rdf:type schema:CreativeWork
218 https://doi.org/10.7326/0003-4819-145-4-200608150-00004 schema:sameAs https://app.dimensions.ai/details/publication/pub.1073708888
219 rdf:type schema:CreativeWork
220 https://www.grid.ac/institutes/grid.419658.7 schema:alternateName Steno Diabetes Center
221 schema:name Steno Diabetes Center, Niels Steensens Vej 1, NLC, 2820, Gentofte, Denmark
222 rdf:type schema:Organization
223 https://www.grid.ac/institutes/grid.475435.4 schema:alternateName Rigshospitalet
224 schema:name Glostrup University Hospital, Glostrup, Denmark
225 rdf:type schema:Organization
226 https://www.grid.ac/institutes/grid.5645.2 schema:alternateName Erasmus University Medical Center
227 schema:name Erasmus MC, Rotterdam, the Netherlands
228 rdf:type schema:Organization
229 https://www.grid.ac/institutes/grid.7048.b schema:alternateName Aarhus University
230 schema:name Faculty of Health Science, University of Aarhus, Aarhus, Denmark
231 Rigshospitalet, Department of Medical Endocrinology, University Hospital of Copenhagen, Copenhagen, Denmark
232 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...